Artificial Labs
Building the foundations of modern specialty (re)insurance | Insurance Technology: Fact or Fiction? podcast
Published Sep 17, 2026
| Starting Price | Not publicly listed (likely enterprise quote) | Not publicly listed (enterprise quote) | Not publicly listed (enterprise quote) |
| Best For | Lloyd’s/London Market brokers & carriers seeking structured MRCv3 contract workflows and underwriting/placement tooling | Carriers focusing on pricing/rating modernization and underwriting decision workflows (esp. specialty/commercial P&C) | Insurers needing core system modernization and expanding pricing/rating lifecycle tooling |
| Key Strength | London Market standards alignment (MRCv3/CDR, Blueprint Two); broker-focused Contract Builder plus underwriting tooling | Focus on pricing/underwriting workflow capabilities; vendor-claimed underwriting-performance improvements | Large installed base; broad suite; ecosystem integration |
| Key Weakness | Limited public third-party product reviews; pricing opacity; integration/standardization change burden likely | Some performance/ROI claims are vendor-published; pricing not transparent | Implementation cost/complexity; change management and time-to-value can be significant |
—
The vendor has received venture backing and press coverage for multiple financing events. However, public evidence of broad-based adoption (for example, extensive third-party reviews or independently measured case study metrics) remains limited.